ŌURA Secures $200M Series D Funding to Drive AI Innovation and Global Expansion
ŌURA, the Finland-based creator of the pioneering Oura Ring, has closed its $200 million Series D funding round, elevating the company’s valuation to $5.2 billion. Led by Fidelity Management & Research Company and Dexcom, a leader in glucose biosensing, the investment underscores confidence in ŌURA’s smart ring category leadership and its transformative potential in personal health wearables.
The funding will accelerate ŌURA’s ambitious roadmap, which includes expanding its product portfolio, advancing AI-powered healthcare innovations, and fueling global market growth. Notable milestones already achieved include the launch of the Oura Ring 4 with cutting-edge Smart Sensing technology and broader health metrics like Heart Health, Women’s Health, and Stress Monitoring. “ŌURA is revolutionizing how we integrate health insights into everyday life,” said CEO Tom Hale. “This investment enables us to innovate further and scale life-changing health solutions globally.”
ŌURA’s momentum is evident in surpassing 2.5 million rings sold and doubling its revenue and membership base in the past year. Strategic moves like retail collaborations with Amazon and Target and acquisitions such as Veri and Sparta Science showcase ŌURA’s commitment to broadening its health ecosystem. By blending technological precision, AI-driven insights, and healthcare partnerships, ŌURA is redefining wearables, enabling individuals to better understand and optimize their health.
